McDermott Will & Schulte

McDermott Will & Schulte fields a well-established life sciences practice advising on corporate, regulatory, IP, and litigation matters across the product lifecycle. The group handles complex domestic and cross-border transactions, patent disputes, and regulatory issues for clients ranging from early-stage companies to established global businesses. The firm demonstrates particular strength in transactional and corporate work, supported by a dedicated IP strategy, prosecution, and high-impact litigation team. Kristian Werling serves as global head of the health and life sciences practice from Chicago and represents private equity and strategic investors in a wide range of transactional matters within the sector. Washington, DC-based Michael Ryan co-heads the firm’s life sciences industry practice and advises manufacturers, healthcare providers, and drug and technology developers on sector-specific legal issues. Also in DC, James Ravitz, co-head of the life sciences industry practice and head of the FDA practice, advises on regulatory compliance, consumer protection investigations, government enforcement matters, and broader FDA regulatory issues affecting life sciences and healthcare clients.